Sysmex

Skip Navigation

Search

Press Releases rss

開閉ボタン

Jun. 03, 2019 Management & Business Management & Business
World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories
-Contributing to Clean and Fair Sports Management by Enhancing the Quality of Doping Tests-
May. 31, 2019 Products & Solution Products & Solution
The OncoGuide™ NCC Oncopanel System Receives Insurance Coverage for Use in Cancer Genome Profiling
May. 27, 2019 Research & Development Research & Development
Sysmex and Osaka University Sign Comprehensive Collaboration Agreement to Foster Innovation in the Healthcare Field
May. 08, 2019 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2019 (PDF:389KB)
May. 08, 2019 Investor Relations Investor Relations
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2019 (PDF:59KB)
May. 08, 2019 Investor Relations Investor Relations
Notice of the Booking of an Extraordinary Loss (Non-Consolidated) in Relation to an Affiliated Company (PDF:27KB)
May. 08, 2019 Investor Relations Investor Relations
Announcement Related to Granting of Stock Options (Stock Acquisition Rights) as a Part of Compensation to Members of the Managing Board (PDF:89KB)
May. 08, 2019 Management & Business Management & Business
Announcement of Executive Change (PDF:130KB)
May. 08, 2019 Management & Business Management & Business
Sysmex Announces New Group Mid-Term Management Plan
-Working to Enhance the Group’s Growth Potential and Reinforce the Management Base with a View to Sustainable Growth- (PDF:117KB)
May. 08, 2019 Management & Business Management & Business
Sysmex Opens Technopark East Site, a Bio-Diagnostic Reagent Base
-Strengthening Diagnostic Reagent Functions through an Integrated Structure from the Development of Substances to the Development, Production and Distribution of Bio-Diagnostic Reagents-

Press Releases